Melanoma
Nivolumab Plus Ipilimumab in Advanced Melanoma: 10-Year Survival Outcomes
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
Nivolumab Plus Ipilimumab in Advanced Melanoma: 10-Year Survival Outcomes
ESMO 2024: Intracranial Activity of T-DXd in HER2-Positive Metastatic Breast Cancer
Efficacy and Safety of First-Line Nivolumab Combinations in Melanoma
Worldwide Incidence of HPV Genotypes in Invasive Cervical Cancer
Symptom-Triggered Testing for High-Grade Serous Ovarian Cancer
Differences in Cancer Rates Among Generations in the United States
Mediterranean Diet’s Effects on Mortality Among Long-Term Cancer Survivors
ASCO 2024: Efficacy and Safety of Triplet in Advanced Melanoma
Resectable Pancreatic Cancer: Perioperative Modified FOLFIRINOX
Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting
Acupuncture for Hot Flashes in Patients With HR-Positive Breast Cancer
ASCO 2024: Osimertinib After Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
ASCO 2024: T-DXd in Previously Treated Patients With Metastatic Breast Cancer
ASCO 2024: Menopausal Hormone Therapy and Ovarian and Endometrial Cancers
Using MRI to Guide Neoadjuvant Chemotherapy for Breast Cancer
Final Results From the ASCENT Trial in Metastatic Triple-Negative Breast Cancer
Pembrolizumab as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma
Risk-Reducing Mastectomy and Breast Cancer Mortality in Patients With a BRCA Mutation
Adjuvant Treatment Deintensification for HPV-Associated Oropharyngeal Cancer
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome
Metastatic Castration-Resistant Prostate Cancer: Tumor Mutational Burden and Therapy Response
Breast Cancer Incidence Among U.S. Women Aged 20 to 49 Years
ASCO GU 2024: Cabozantinib and Atezolizumab in Metastatic Castration-Resistant Prostate Cancer
ASCO GI 2024: ctDNA as a Predictive Biomarker for Patients With Colon Cancer
ASCO GI 2024: Radioligand Therapy for Gastroenteropancreatic Neuroendocrine Tumors
Racial and Ethnic Disparities in Hormone Therapy Receipt Among Patients With Prostate Cancer
ASH 2023: Auto-HCT vs CAR T-Cell Therapy in Patients With LBCL
SABCS 2023: Determining Impact of Treatment De-escalation in Breast Cancer
SABCS 2023: HER2CLIMB-02 Trial in Metastatic HER2-Positive Breast Cancer
ESMO 2023: Determining Standard-of-Care Therapy for Medullary Thyroid Carcinoma
ESMO 2023: Adding a PARP Inhibitor to Chemoimmunotherapy in Advanced Endometrial Cancer
Novel Antibody-Drug Conjugate for CLDN18.2-Positive Gastric and GEJ Cancers
ESMO 2023: Sotorasib Plus Panitumumab in Refractory KRAS G12C–Mutated Colorectal Cancer
ESMO 2023: Pre- and Postsurgical Immunotherapy for Resectable Early-Stage NSCLC
Side-Specific Cellular Physiology in Colon Cancer Liver Metastasis
Vitamin D Levels in Patients With Leukemia Undergoing Stem Cell Transplant
Tobacco Cessation Treatment in Patients Eligible for Lung Cancer Screening
Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors
CAR T-Cell Therapy for Patients With CLL/SLL: TRANSCEND CLL 004
Real-World Genomic Testing and Treatment Patterns for Adult Patients Newly Diagnosed With Leukemia
Patterns in Early-Onset Cancer Incidence Among U.S. Patients From 2010 to 2019
Survival and Prognostic Factors of Adults With Acute Leukemia Living in Uganda
NCCN Guidelines: Adolescent and Young Adult (AYA) Oncology, Version 2.2024
Tailoring Treatment for Children With IKZF1-Deleted Acute Lymphocytic Leukemia
Maintenance Therapy With Selinexor in Patients With Endometrial Cancer
Pembrolizumab vs Ipilimumab in Advanced Melanoma: Long-Term Follow-up
How Do Mental Health Disorders Affect Survival Among Patients With Lymphoma?
Bonus Protections From a Vaccine Commonly Used in Bladder Cancer?
Pirtobrutinib in Pretreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Age-Based Inequality in Molecular Monitoring of Chronic Myeloid Leukemia
Impact of MRD Status on Survival Outcomes After Fixed-Duration Therapy in Patients With CLL
Factors Associated With Nonadherence to Lung Cancer Screening
Patient-Reported Outcomes in the PROSPECT Trial of Locally Advanced Rectal Cancer
ASCO 2023: Patient Outcomes Following Brexucabtagene Autoleucel for Relapsed/Refractory B-Cell ALL
ASCO 2023: Adjuvant Ribociclib Plus Endocrine Therapy in Early-Stage Breast Cancer
ASCO 2023: INDIGO Trial of Vorasidenib for Select Patients With Brain Tumors
ASCO 2023: PROSPECT Trial Examines Role of Radiation in Locally Advanced Rectal Cancer
Temporary Interruption of Endocrine Therapy to Attempt Pregnancy in Patients With Breast Cancer
ASCO 2023: International Cooperation and Pediatric Leukemia Outcomes
NCCN Guidelines: Acute Myeloid Leukemia, Version 3.2023, Focus on BPDCN
Psilocybin Therapy for Patients With Cancer and Major Depression Disorder
Understanding Prostate Cancer Incidence in Transgender Women
NCCN Guidelines: Esophageal and Esophagogastric Junction Cancers, Version 2.2023
AACR 2023: Does Pembrolizumab Improve Outcomes in Biliary Tract Cancer?
Blinatumomab Plus Interfant-06 Chemotherapy in Infants With KMT2A-Rearranged ALL
Poverty’s Impact on Outcomes in Pediatric Acute Lymphoblastic Leukemia
Dietary Intervention for Improvement of Side Effects Among DLBCL Survivors
Mediterranean Diet and Outcomes Among Patients With Advanced Melanoma Receiving Immunotherapy
Ide-cel vs Standard Regimens for Patients With Relapsed and Refractory Multiple Myeloma
Rate of COVID-19 Vaccination Among Patients With Cancer Who Tested Positive for SARS–CoV-2
Radiotherapy Techniques for Patients With Locally Advanced, Recurrent Nasopharyngeal Cancer
Determining Risk of Relapse After Bone Marrow Transplant Among Patients With AML
Rapid Changes in Colorectal Cancer Statistics: American Cancer Society Report
Ethnic Disparities in Pediatric Leukemia Survival and U.S./Mexico Border Residence
ASCO GU 2023: Rucaparib or Physician’s Choice in Metastatic Castration-Resistant Prostate Cancer
Is Childhood Leukemia Linked to Maternal Infection During Pregnancy?
ASCO GU 2023: Talazoparib Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Ponatinib vs Imatinib for Newly Diagnosed Patients With Ph-Positive ALL
New Ovarian Cancer Risk-Control Guidance Suggests Early Surgical Intervention
Food Insecurity and Receipt of SNAP Benefits Among Pediatric Patients With ALL
ASCO GI 2023: NAPOLI-3 Trial in Metastatic Pancreatic Ductal Adenocarcinoma
ASCO GI 2023: Zolbetuximab Plus mFOLFOX6 For Certain Patients With Advanced Gastric Cancers
ASH 2022: Zanubrutinib in Patients With Relapsed or Refractory CLL/SLL
ASH 2022: Efficacy of Triplet Combinations in Acute Myeloid Leukemia
Safety and Efficacy of Sotorasib in KRAS-Mutated Pancreatic Cancer
ASH 2022: Impact of Momelotinib on Patient-Reported Quality of Life for Patients With Myelofibrosis
ASH 2022: Talquetamab for Relapsed or Refractory Multiple Myeloma
Risk of ALCL Following Postmastectomy Implant Reconstruction
SABCS 2022: First-Line Ribociclib Plus Endocrine Therapy in Patients With Aggressive Breast Cancer
ASH 2022: Re-evaluating the Standard of Care in Mantle Cell Lymphoma
Patients With Multiple Myeloma Receiving Salvage Treatment After BCMA-Directed CAR T-Cell Therapy
Integrative Approaches to Managing Pain in Patients With Cancer: SIO/ASCO Guideline
Subset of Patients With a Very Low Risk of Dying From Melanoma
NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas (Version 3.2022)
Real-World Cost of Pediatric ALL Care Among Commercially Insured Patients
ASTRO 2022: A Novel Approach for Radiotherapy in Orbital Indolent B-Cell Lymphoma
ESMO 2022: Pembrolizumab and Chemoradiation for Locally Advanced Head and Neck Cancer
Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer
Physician Survey: Breast Cancer Screening Among Transgender Patients
Anaplastic Large-Cell Lymphoma of the Breast: Incidence in the United States
ESMO 2022: COSMIC-313 Trial of Triplet Therapy in Advanced Renal Cell Carcinoma
Trends in Improvements in Survival Among Patients With DLBCL
Consumption of Ultraprocessed Foods and Colorectal Cancer Risk
ESMO 2022: Air Pollution and Non–Small Cell Lung Cancer Risk
ESMO 2022: SWOG S1801 Trial of Timing of Pembrolizumab in Resected Advanced Melanoma
Trends in Cutaneous T-Cell Lymphoma Incidence in the United States
Diet Quality and Survival Among Patients With Head and Neck Cancer
UV-Protective Behaviors Among American Indians and Alaskan Natives
Germline Testing for Patients With Lung Cancer: ASCO Plenary Series
Older Patients With Advanced Bladder Cancer: Care Planning Priorities
Dosing of Tisagenlecleucel Among Pediatric Patients With Leukemia and Improved Outcomes
Acute Leukemia Survival Outcomes Over Time in South Australia
Real-World Outcomes With Axicabtagene Ciloleucel Therapy for Large B-Cell Lymphoma
Multiple Myeloma: Caregiver Quality of Life and Psychological Distress
Phase III Trial Evaluates Quizartinib for FLT3-ITD–Positive AML
Zanubrutinib for Untreated Patients With CLL/SLL: SEQUOIA Trial
Rapid Recommendation Update to ASCO Guideline for Systemic Treatment of Melanoma
Trends in the Use of Medical Aid in Dying in the United States
ASCO 2022: Asciminib vs Bosutinib in Pretreated Patients With CML in Chronic Phase
Characteristics of Advanced Extranodal Natural Killer/ T-Cell Lymphoma and its Treatment
Results From Large Real-World Cohorts on Treatment Outcomes in Patients With Mantle Cell Lymphoma
Consumption of Sugar-Sweetened Beverages and Risk of Liver Cancer
ASCO 2022: Real-World Data on Maintenance Olaparib in BRCA-Mutated Ovarian Cancer
ASCO 2022: Crenolanib Combined With Chemotherapy in Newly Diagnosed FLT3-Mutant AML
ASCO 2022: Dostarlimab-gxly in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
ASCO 2022: Nimotuzumab Plus Gemcitabine for KRAS Wild-Type Pancreatic Cancer
ASCO 2022: New Data on IDH2-Mutant Alleles and Endasidenib in AML
The Financial Burden of Thyroid Cancer Care in the United States
ASCO 2022: Sacituzumab Govitecan-hziy for HR-Positive/HER2-Negative Advanced Breast Cancer
ASCO 2022: Measurable Residual Disease Testing as Prognostic Tool in Acute Myeloid Leukemia
ASCO 2022: Adding ASCT to Triplet/Maintenance Therapy for Newly Diagnosed Multiple Myeloma
ASCO 2022: Panitumumab Plus mFOLFOX6 for Certain Patients With Metastatic Colorectal Cancer
ASCO 2022: T-DXd in HER2-Low Unresectable and/or Metastatic Breast Cancer
ASCO 2022: Using ctDNA to Guide Adjuvant Chemotherapy in Colon Cancer
ASCO 2022: Ibrutinib Added to Bendamustine/Rituximab for Older Patients With Mantle Cell Lymphoma
ASCO 2022: State Public Welfare Spending and Disparities in Overall Survival
ASCO 2022: Black Patient Participation in Clinical Trials for Metastatic Breast Cancer
ASCO 2022: Disparities in Telemedicine Use for Patients With Cancer During the COVID-19 Pandemic
NCCN Guidelines for Non–Small Cell Lung Cancer (Version 3.2022)
CAR T-Cell Therapy: Rates of Rehospitalization and Emergency Department Visits Postinfusion
Addition of Ivosidenib to Azacitidine in Newly Diagnosed IDH1-Mutated AML
Total Burden of Psychiatric Disorders Across All Common Adult Cancers
Innate Cell Engager AFM13 Plus Natural Killer Cells for Lymphoma
Tislelizumab Plus Chemotherapy for Recurrent/Metastatic Nasopharyngeal Cancer: RATIONALE-309
MSI-H/dMMR Advanced Colorectal Cancer: Pembrolizumab vs Chemotherapy
CheckMate 816: Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC
NCCN Guidelines for the Management of Immunotherapy-Related Toxicities (Version 1.2022)
Rucaparib vs Standard-of-Care Chemotherapy for BRCA1/2-Mutated, Relapsed Ovarian Cancer
Immune Responses Among Patients With B-Cell Malignancies Post–COVID-19 Vaccination
Combined BCMA and CD19 CAR T-Cells in Relapsed or Refractory Multiple Myeloma
Pembrolizumab/Trametinib vs Gemcitabine in Addition to SBRT for Pancreatic Cancer
Immunotherapy Doublet in Patients With MSI-H/dMMR Metastatic Colorectal Cancer
Strategy for De-Escalating Radiation Therapy for Patients With Oropharyngeal Cancer
Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer
Communication Skills Challenges for Advanced Practice Providers
Outcomes of Patients With an Ultra-Low–Risk 70-Gene Signature in the MINDACT Trial
Polatuzumab Vedotin-piiq Plus R-CHP vs R-CHOP in Previously Untreated DLBCL: POLARIX Trial
Combination Anti–PD-L1 and Anti–CTLA-4 Immunotherapy in Advanced Liver Cancer
Cancer During COVID-19: Resilience of Patients With Lung Cancer
Using PET Scans to Direct Therapy Decisions in Advanced Hodgkin Lymphoma
AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care
Mosunetuzumab for Relapsed or Refractory Aggressive and Indolent B-Cell Non-Hodgkin Lymphomas
TOPAZ-1 Trial: Durvalumab and Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
Treatment Options for Patients With GIST Following Disease Progression
Managing Breakthrough Cancer Pain: Role of Shared Decision-Making
Tebentafusp-tebn for the Treatment of Unresectable or Metastatic Uveal Melanoma
T-DXd in Previously Treated Patients With Metastatic HER2-Mutant NSCLC
Case-Control Study of Risk of Cardiometabolic Risk Factors in Breast Cancer Survivors
BNT162b2 COVID-19 Vaccination and Immune Response in Patients Undergoing Anticancer Treatment
Dual Checkpoint Inhibition for Second-Line Treatment of Advanced Cervical Cancer
Emerging Therapies and Current Unmet Needs for Patients With Relapsed or Refractory DLBCL
Relatlimab and Nivolumab vs Nivolumab Alone in Untreated Advanced Melanoma
Treatment-Related Regret Among Men With Localized Prostate Cancer: Examining Potential Factors
COVID-19 Vaccination and SARS–CoV-2 Infection Among Patients With Cancer